ImmuPharma plc (LON:IMM – Get Free Report)’s share price dropped 0.1% during mid-day trading on Monday . The stock traded as low as GBX 3.20 ($0.04) and last traded at GBX 3.67 ($0.04). Approximately 28,360,365 shares changed hands during mid-day trading, a decline of 9% from the average daily volume of 31,251,598 shares. The stock had previously closed at GBX 3.67 ($0.04).
ImmuPharma Stock Down 3.5 %
The stock has a market cap of £12.86 million, a P/E ratio of -308.90 and a beta of 1.53. The firm’s fifty day moving average price is GBX 1.48 and its 200-day moving average price is GBX 1.66.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Read More
- Five stocks we like better than ImmuPharma
- How Investors Can Find the Best Cheap Dividend Stocks
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- Best Stocks Under $10.00
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- Expert Stock Trading Psychology Tips
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
